Novel treatment possibilities of invasive aspergillosis
Invasive aspergillosis is the leading fungal infection in patients with hematological malignancies. The review represents the incidence of invasive aspergillosis in different groups of patients, risk factors for its development, treatment options, including the new drug isavuconazole.
Saved in:
| Main Author: | G. A. Klyasova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2021-11-01
|
| Series: | Онкогематология |
| Subjects: | |
| Online Access: | https://oncohematology.abvpress.ru/ongm/article/view/502 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effectiveness, Safety, and Patterns of Real-World Isavuconazole Use in Europe (2015–2019)
by: Dionysios Neofytos, et al.
Published: (2024-10-01) -
Current Challenges in the Treatment of Invasive Aspergillosis in Geriatric Patients
by: Sara Fueyo Álvarez, et al.
Published: (2025-06-01) -
INVASIVE ASPERGILLOSIS AS A MANIFESTATION OF SUPERINFECTION IN THE PRESENCE OF SEVERE STAPHYLOCOCCUS PNEUMONIA
by: A. V. Ezhov, et al.
Published: (2015-10-01) -
Invasive pulmonary aspergillosis in COVID-19 patients
by: V. G. Gusarov, et al.
Published: (2021-03-01) -
Invasive aspergillosis in adult patients with rheumatic diseases
by: V. I. Mazurov, et al.
Published: (2020-11-01)